Search

Your search keyword '"Pigatto, Paolo"' showing total 834 results
Start Over Author "Pigatto, Paolo"
834 results on '"Pigatto, Paolo"'

1. AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

Author

Stingeni, Luca, Chiricozzi, Andrea, Calzavara-Pinton, Piergiacomo, Napolitano, Maddalena, Peris, Ketty, Schena, Donatella, Patruno, Cataldo, Rossi, Mariateresa, Foti, Caterina, Fargnoli, Maria C., Corazza, Monica, Ferrucci, Silvia M., Pigatto, Paolo D., Romanelli, Marco, Fabbrocini, Gabriella, Girolomoni, Giampiero, Passante, Maria, Romita, Paolo, Esposito, Maria, Schettini, Natale, Marzano, Angelo V., Tonini, Giulia, Marietti, Rossella, Casciola, Gabriele, Argenziano, Giuseppe, and Hansel, Katharina

Published
2024
Full Text
View/download PDF

3. Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

Author

Stingeni, Luca, Chiricozzi, Andrea, Calzavara-Pinton, Piergiacomo, Napolitano, Maddalena, Peris, Ketty, Schena, Donatella, Patruno, Cataldo, Rossi, Mariateresa, Foti, Caterina, Fargnoli, Maria C., Corazza, Monica, Ferrucci, Silvia M., Pigatto, Paolo D., Romanelli, Marco, Fabbrocini, Gabriella, Girolomoni, Giampiero, Passante, Maria, Romita, Paolo, Esposito, Maria, Schettini, Natale, Marzano, Angelo V., Tonini, Giulia, Marietti, Rossella, Casciola, Gabriele, Argenziano, Giuseppe, and Hansel, Katharina

Published
2024
Full Text
View/download PDF

5. Photopatch Testing

Author

Pigatto, Paolo Daniele Maria, Pacifico, Alessia, Damiani, Giovanni, Cristaudo, Antonio, Angelini, Gianni, editor, Bonamonte, Domenico, editor, Foti, Caterina, editor, and Pragnell, Mary VC, Translated by

Published
2021
Full Text
View/download PDF

6. Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)

Author

ARGENZIANO, Giuseppe, primary, CUSANO, Francesco, additional, CORAZZA, Monica, additional, AMATO, Salvatore, additional, AMERIO, Paolo, additional, NALDI, Luigi, additional, PATRUNO, Cataldo, additional, PIGATTO, Paolo D., additional, QUAGLINO, Pietro, additional, GISONDI, Paolo, additional, CHIRICOZZI, Andrea, additional, TONON, Francesco, additional, STINGENI, Luca, additional, CALZAVARA-PINTON, Piergiacomo, additional, WOLLENBERG, Andreas, additional, KINBERGER, Maria, additional, ARENTS, Bernd W., additional, ASZODI, Nora, additional, AVILA VALLE, Gabriela L., additional, BARBAROT, Sebastien, additional, BIEBER, Thomas, additional, BROUGH, Helen A., additional, CHRISTEN-ZÄCH, Stéphanie, additional, DELEURAN, Mette, additional, DITTMANN, Martin, additional, DRESSLER, Corinna, additional, FINK-WAGNER, Antjie H., additional, FOSSE, Nicole, additional, GÁSPÁR, Krisztián, additional, GERBENS, Louise A., additional, GIELER, Uwe, additional, GIROLOMONI, Giampiero, additional, GREGORIOU, Stamatios, additional, MORTZ, Charlotte G., additional, NAST, Alexander, additional, NYGAARD, Uffe, additional, REDDING, Magali, additional, REHBINDER, Eva M., additional, RING, Johannes, additional, ROSSI, Mariateresa, additional, SERRA-BALDRICH, Esther, additional, SIMON, Dagmar, additional, SZALAI, Zsuzsanna Z., additional, SZEPIETOWSKI, Jacek C., additional, TORRELO, Antonio, additional, WERFEL, Thomas, additional, and FLOHR, Carsten, additional

Published
2024
Full Text
View/download PDF

7. Italian S3-Guideline on the treatment of atopic eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)

Author

ARGENZIANO, Giuseppe, primary, CUSANO, Francesco, additional, CORAZZA, Monica, additional, AMATO, Salvatore, additional, AMERIO, Paolo, additional, NALDI, Luigi, additional, PATRUNO, Cataldo, additional, PIGATTO, Paolo D., additional, QUAGLINO, Pietro, additional, GISONDI, Paolo, additional, CHIRICOZZI, Andrea, additional, TONON, Francesco, additional, STINGENI, Luca, additional, CALZAVARA-PINTON, Piergiacomo, additional, WOLLENBERG, Andreas, additional, KINBERGER, Maria, additional, ARENTS, Bernd W., additional, ASZODI, Nora, additional, AVILA VALLE, Gabriela L., additional, BARBAROT, Sebastien, additional, BIEBER, Thomas, additional, BROUGH, Helen A., additional, CHRISTEN-ZÄCH, Stéphanie, additional, DELEURAN, Mette, additional, DITTMANN, Martin, additional, DRESSLER, Corinna, additional, FINK-WAGNER, Antjie H., additional, FOSSE, Nicole, additional, GÁSPÁR, Krisztián, additional, GERBENS, Louise A., additional, GIELER, Uwe, additional, GIROLOMONI, Giampiero, additional, GREGORIOU, Stamatios, additional, MORTZ, Charlotte G., additional, NAST, Alexander, additional, NYGAARD, Uffe, additional, REDDING, Magali, additional, REHBINDER, Eva M., additional, RING, Johannes, additional, ROSSI, Mariateresa, additional, SERRA-BALDRICH, Esther, additional, SIMON, Dagmar, additional, SZALAI, Zsuzsanna Z., additional, SZEPIETOWSKI, Jacek C., additional, TORRELO, Antonio, additional, WERFEL, Thomas, additional, and FLOHR, Carsten, additional

Published
2024
Full Text
View/download PDF

8. Italian S3-Guideline on the treatment of atopic eczema Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)

Author

ARGENZIANO, Giuseppe, primary, CUSANO, Francesco, additional, CORAZZA, Monica, additional, AMATO, Salvatore, additional, AMERIO, Paolo, additional, NALDI, Luigi, additional, PATRUNO, Cataldo, additional, PIGATTO, Paolo D., additional, QUAGLINO, Pietro, additional, GISONDI, Paolo, additional, CHIRICOZZI, Andrea, additional, TONON, Francesco, additional, STINGENI, Luca, additional, CALZAVARA-PINTON, Piergiacomo, additional, WOLLENBERG, Andreas, additional, KINBERGER, Maria, additional, ARENTS, Bernd W., additional, ASZODI, Nora, additional, AVILA VALLE, Gabriela L., additional, BARBAROT, Sebastien, additional, BIEBER, Thomas, additional, BROUGH, Helen A., additional, CHRISTEN-ZÄCH, Stéphanie, additional, DELEURAN, Mette, additional, DITTMANN, Martin, additional, DRESSLER, Corinna, additional, FINK-WAGNER, Antjie H., additional, FOSSE, Nicole, additional, GÁSPÁR, Krisztián, additional, GERBENS, Louise A., additional, GIELER, Uwe, additional, GIROLOMONI, Giampiero, additional, GREGORIOU, Stamatios, additional, MORTZ, Charlotte G., additional, NAST, Alexander, additional, NYGAARD, Uffe, additional, REDDING, Magali, additional, REHBINDER, Eva M., additional, RING, Johannes, additional, ROSSI, Mariateresa, additional, SERRA-BALDRICH, Esther, additional, SIMON, Dagmar, additional, SZALAI, Zsuzsanna Z., additional, SZEPIETOWSKI, Jacek C., additional, TORRELO, Antonio, additional, WERFEL, Thomas, additional, and FLOHR, Carsten, additional

Published
2024
Full Text
View/download PDF

9. Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

Author

Chiricozzi, Andrea, Di Nardo, Lucia, Talamonti, Marina, Galluzzo, Marco, De Simone, Clara, Fabbrocini, Gabriella, Marzano, Angelo Valerio, Girolomoni, Giampiero, Offidani, Annamaria, Rossi, Maria Teresa, Bianchi, Luca, Cristaudo, Antonio, Fierro, Maria Teresa, Stingeni, Luca, Pellacani, Giovanni, Argenziano, Giuseppe, Patrizi, Annalisa, Pigatto, Paolo, Romanelli, Marco, Savoia, Paola, Rubegni, Pietro, Foti, Caterina, Milanesi, Nicola, Belloni Fortina, Anna, Bongiorno, Maria Rita, Grieco, Teresa, Di Nuzzo, Sergio, Fargnoli, Maria Concetta, Carugno, Andrea, Motolese, Alberico, Rongioletti, Franco, Amerio, Paolo, Balestri, Riccardo, Potenza, Concetta, Micali, Giuseppe, Patruno, Cataldo, Zalaudek, Iris, Lombardo, Maurizio, Feliciani, Claudio, Antonelli, Flaminia, Ferrucci, Silvia Mariel, Guarneri, Fabrizio, and Peris, Ketty

Published
2021
Full Text
View/download PDF

10. Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

Author

Chiricozzi, Andrea, Di Nardo, Lucia, Talamonti, Marina, Galluzzo, Marco, De Simone, Clara, Fabbrocini, Gabriella, Marzano, Angelo Valerio, Girolomoni, Giampiero, Offidani, Annamaria, Rossi, Maria Teresa, Bianchi, Luca, Cristaudo, Antonio, Fierro, Maria Teresa, Stingeni, Luca, Pellacani, Giovanni, Argenziano, Giuseppe, Patrizi, Annalisa, Pigatto, Paolo, Romanelli, Marco, Savoia, Paola, Rubegni, Pietro, Foti, Caterina, Milanesi, Nicola, Belloni Fortina, Anna, Bongiorno, Maria Rita, Grieco, Teresa, Di Nuzzo, Sergio, Fargnoli, Maria Concetta, Carugno, Andrea, Motolese, Alberico, Rongioletti, Franco, Amerio, Paolo, Balestri, Riccardo, Potenza, Concetta, Micali, Giuseppe, Patruno, Cataldo, Zalaudek, Iris, Lombardo, Maurizio, Feliciani, Claudio, Antonelli, Flaminia, Ferrucci, Silvia Mariel, Guarneri, Fabrizio, and Peris, Ketty

Published
2022
Full Text
View/download PDF

12. Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study.

Author

Stingeni, Luca, Foti, Caterina, Guarneri, Fabrizio, Corazza, Monica, Cristaudo, Antonio, Ferrucci, Silvia Mariel, Gallo, Rosella, Martina, Emanuela, Musumeci, Maria Letizia, Napolitano, Maddalena, Nettis, Eustachio, Patruno, Cataldo, Pigatto, Paolo Daniele, Piras, Viviana, Schena, Donatella, Casciola, Gabriele, Antonelli, Elettra, Hansel, Katharina, Bianchi, Leonardo, and Borghi, Alessandro

Abstract

Background: Eyelid dermatitis is a frequent reason of dermatological consultation. Its aetiology is not univocal, being contact dermatitis, both allergic and irritant, the most frequent. The primary sources of allergen exposure include cosmetics, metals, and topical medications, from direct, indirect, or airborne contact. Objectives: To define the frequency of positive patch test reactions to SIDAPA baseline series allergens, to document positive allergens, and to precise the final diagnosis in patients with eyelid involvement. Methods: A total of 8557 consecutive patients from 12 Italian Dermatology Clinics underwent patch testing with SIDAPA baseline series in 2018 and 2019. Patients were divided into two groups: (i) with eyelid involvement with or without other involved sites (E‐Group) and (ii) without eyelid involvement (NE‐Group). The final diagnosis and the frequency of positive relevant patch test reactions were evaluated. Results: E‐Group consisted of 688 patients (females 78.6%, mean age 45.3 years), 8.0% of 8557 consecutively patch‐tested patients. The final diagnosis in E‐Group was ADC in 42.4%, ICD in 34.2%, and AD in 30.5%. The highest reaction rates were elicited by nickel sulphate and methylchloroisothiazolinone/methylisothiazolinone in both E‐Group and NE‐Group, even if these allergens were significantly more frequently positive in NE‐Group patients than in E‐Group ones. Positive patch test reactions to fragrance Mix II, dimethylaminopropylamine, and sorbitan sesquiolate were significantly more frequent in E‐Group patients than in NE‐Group ones. Conclusions: Eyelid dermatitis is a frequent dermatological complaint. Allergic contact dermatitis is the most frequent diagnosis commonly caused by nickel sulphate, isothiazolinones, and fragrances. The surfactants dimethylaminopropylamine and sorbitan sesquioleate are emerging causes of eyelid allergic contact dermatitis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis

Author

Adawi, Mohammad, Bragazzi, Nicola Luigi, McGonagle, Dennis, Watad, Samaa, Mahroum, Naim, Damiani, Giovanni, Conic, Rosalynn, Bridgewood, Charlie, Mahagna, Hussein, Giacomelli, Luca, Eggenhöffner, Roberto, Mahamid, Mahmud, Pigatto, Paolo Daniele Maria, Amital, Howard, and Watad, Abdulla

Published
2019
Full Text
View/download PDF

14. Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis

Author

Prignano, Francesca, primary, Argenziano, Giuseppe, additional, Bardazzi, Federico, additional, Borroni, Riccardo G., additional, Brunasso, Alexandra M. G., additional, Burlando, Martina, additional, Cagni, Anna Elisabetta, additional, Campione, Elena, additional, Cinotti, Elisa, additional, Colonna, Fabrizio, additional, Cuccia, Aldo, additional, Dastoli, Stefano, additional, De Pasquale, Rocco, additional, De Simone, Clara, additional, Di Lernia, Vito, additional, Dini, Valentina, additional, Fabbrocini, Gabriella, additional, Galluzzi, Claudia, additional, Giacchetti, Alfredo, additional, Giofrè, Claudia, additional, Lasagni, Claudia, additional, Lembo, Serena, additional, Loconsole, Francesco, additional, Montesu, Maria Antonia, additional, Pella, Paolo, additional, Piaserico, Stefano, additional, Pigatto, Paolo, additional, Richetta, Antonio Giovanni, additional, Scuotto, Adriana, additional, Stroppiana, Elena, additional, Venturini, Marina, additional, Vinci, Anna Stefania, additional, Zichichi, Leonardo, additional, and Fargnoli, Maria Concetta, additional

Published
2023
Full Text
View/download PDF

17. Systemic allergic contact dermatitis associated with allergy to intraoral metals

Author

Pigatto, Paolo D, Brambilla, Lucia, Ferrucci, Silvia, Zerboni, Roberto, Somalvico, Francesco, and Guzzi, Gianpaolo

Subjects
adverse events, amalgam dermatitis, contact hypersensitivity reaction, delayed/chemically induced, delayed-type hypersensitivity, dermatitis/allergic contact hypersensitivity, heavy metals adverse events, mercury dermatitis, mercury exanthema
Abstract

Contact (allergic) dermatitis is a skin disorder related to natural exposure to various allergens. Systemic contact dermatitis (SCD) describes a cutaneous eruption in response to systemic exposure to an allergen. The exact pathologic mechanism remains uncertain. Herein we describe a 36-year-old woman with symmetric systemic allergic contact dermatitis, unresponsive to conventional treatment, associated with dental alloy-contact hypersensitivity. We did skin patch testing and the blood lymphocyte transformation test (LTT) from the dental allergen series to assess contact allergy to restorative dental materials. On patch testing, positive allergic contact dermatitis reactions to metals occurred (nickel, potassium dichromate, and gold). Nickel hypersensitivity was confirmed by LTT, which also revealed silver-amalgam sensitization. Our case report highlights the need to consider adverse reactions to base-metal dental alloys in the differential diagnosis of cases of systemic allergic contact dermatitis.

Published
2014

18. Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice

Author

Baiardini, Ilaria, Braido, Fulvio, Molinengo, Giorgia, Caminati, Marco, Costantino, MariaTeresa, Cristaudo, Antonio, Crivellaro, Mariangiola, Ferrucci, Silvia Mariel, Gallo, Rosella, Giorgis, Veronica, Legori, Agostina, Loera, Barbara, Martignago, Irene, Marzano, Angelo Valerio, Morrone, Aldo, Parente, Roberta, Parodi, Aurora, Parolo, Anna, Peveri, Silvia, Pigatto, Paolo, Radice, Anna, Ridolo, Erminia, Rolla, Giovanni, Roncallo, Chiara, Rossi, Oliviero, Savi, Eleonora, Senna, Gianenrico, Triggiani, Massimo, and Canonica, Giorgio Walter

Published
2018
Full Text
View/download PDF

19. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology

Author

Nettis, Eustachio, Foti, Caterina, Ambrifi, Marina, Baiardini, Ilaria, Bianchi, Leonardo, Borghi, Alessandro, Caminati, Marco, Canonica, Giorgio Walter, Casciaro, Marco, Colli, Laura, Colombo, Giselda, Corazza, Monica, Cristaudo, Antonio, De Feo, Giulia, De Pita’, Ornella, Di Gioacchino, Mario, Di Leo, Elisabetta, Fassio, Filippo, Gangemi, Sebastiano, Gatta, Alessia, Hansel, Katharina, Heffler, Enrico, Incorvaia, Cristoforo, Napolitano, Maddalena, Patruno, Cataldo, Peveri, Silvia, Pigatto, Paolo Daniele, Quecchia, Cristina, Radice, Anna, Ramirez, Giuseppe Alvise, Romita, Paolo, Rongioletti, Franco, Rossi, Oliviero, Savi, Eleonora, Senna, Gianenrico, Triggiani, Massimo, Zucca, Myriam, Maggi, Enrico, and Stingeni, Luca

Published
2020
Full Text
View/download PDF

21. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients

Author

Pignatti, Patrizia, primary, Ramirez, Giuseppe Alvise, additional, Russo, Marco, additional, Marraccini, Paolo, additional, Nannipieri, Serena, additional, Asperti, Chiara, additional, Torre, Fabrizio Della, additional, Tiri, Antonio, additional, Gatti, Beatrice Maria, additional, Gurrado, Antonella, additional, Meriggi, Antonio, additional, Benanti, Giovanni, additional, Cilona, Maria Bernadette, additional, Pigatto, Paolo, additional, Burastero, Samuele E., additional, Dagna, Lorenzo, additional, and Yacoub, Mona-Rita, additional

Published
2023
Full Text
View/download PDF

22. AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST

Author

FABBROCINI, Gabriella, primary, HANSEL, Katharina, additional, CORAZZA, Monica, additional, FERRUCCI, Silvia M., additional, FARGNOLI, Maria C., additional, FOTI, Caterina, additional, PATRUNO, Cataldo, additional, PERIS, Ketty, additional, PIGATTO, Paolo, additional, ROMANELLI, Marco, additional, ROSSI, Mariateresa, additional, SCHENA, Donatella, additional, MONFRECOLA, Giuseppe, additional, and CALZAVARA-PINTON, Piergiacomo, additional

Published
2023
Full Text
View/download PDF

24. The European baseline series and recommended additions:2023

Author

Wilkinson, S. Mark, Gonçalo, Margarida, Aerts, Olivier, Badulici, Sonia, Dickel, Heinrich, Gallo, Rosella, Garcia-Abujeta, Jose L., Giménez-Arnau, Ana M., Hamman, Curt, Hervella, Marcos, Isaksson, Marléne, Johansen, Jeanne D., Mahler, Vera, Niklasson, Bo, Pigatto, Paolo, Ponyai, Gyorgyi, Rustemeyer, Thomas, Schuttelaar, Marie L.A., Spiewak, Radoslaw, Stingeni, Luca, Thyssen, Jacob P., Uter, Wolfgang, Wilkinson, S. Mark, Gonçalo, Margarida, Aerts, Olivier, Badulici, Sonia, Dickel, Heinrich, Gallo, Rosella, Garcia-Abujeta, Jose L., Giménez-Arnau, Ana M., Hamman, Curt, Hervella, Marcos, Isaksson, Marléne, Johansen, Jeanne D., Mahler, Vera, Niklasson, Bo, Pigatto, Paolo, Ponyai, Gyorgyi, Rustemeyer, Thomas, Schuttelaar, Marie L.A., Spiewak, Radoslaw, Stingeni, Luca, Thyssen, Jacob P., and Uter, Wolfgang

Abstract

The European baseline series was last updated in 2019. This article discusses the reasoning behind a further iteration of the series for 2023., The European baseline series was last updated in 2019. This article discusses the reasoning behind a further iteration of the series for 2023.

Published
2023

25. AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.

Author

Stingeni, Luca, Chiricozzi, Andrea, Calzavara-Pinton, Piergiacomo, Napolitano, Maddalena, Peris, Ketty, Schena, Donatella, Patruno, Cataldo, Rossi, Mariateresa, Foti, Caterina, Fargnoli, Maria C., Corazza, Monica, Ferrucci, Silvia M., Pigatto, Paolo D., Romanelli, Marco, Fabbrocini, Gabriella, Girolomoni, Giampiero, Passante, Maria, Romita, Paolo, Esposito, Maria, and Schettini, Natale

Subjects
ATOPIC dermatitis, RESEARCH funding, QUALITY of life, DEMOGRAPHY, COMORBIDITY, ADULTS
Abstract

Background and Objective: AtopyReg® is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatitis in adults promoted in 2018 by the Italian Society of Dermatology and Venereology (SIDeMaST). We aimed to describe baseline demographics, disease characteristics, comorbidities, and therapeutic data of adult patients affected by moderate-to-severe atopic dermatitis. Methods: Patients were selected based on the following inclusion criteria: age ≥ 18 years; Eczema Area and Severity Index score ≥ 16 or localization in visible or sensitive areas (face, neck, hands, or genitalia), or a Numeric Rating Scale itch score ≥ 7 or a Numeric Rating Scale sleep loss score ≥ 7, or a Dermatology Life Quality Index score ≥ 10. Demographic and clinical data at baseline were recorded and analyzed. Results: A total of 1170 patients (male 51.1%; mean age: 44.7 years; range 18–90 years) were enrolled by 12 Italian Dermatology Units between January 2019 and November 2022. Skin lesions were eczematous in 83.2% of patients, the most involved site were the flexures (53.9%), face (50.9%), and neck (48.0%). Mean Eczema Area and Severity Index score was 22.3, mean Dermatology Life Quality Index value was 17.6, mean Patient Oriented Eczema Measure score was 13.1, and mean Numeric Rating Scale itch and sleep loss scores were 7.6 and 5.9, respectively. Previous systemic therapies were corticosteroids in 77.7% of patients, antihistamines in 50.3% of patients, and cyclosporine A in 42.6% of patients. Conclusions: This baseline data analysis deriving from AtopyReg® provides real-life evidence on patients with moderate-to-severe atopic dermatitis in Italy confirming the high burden of atopic dermatitis with a significant impact on patients' quality of life. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Explicit Tracking in the Diagnostic Process for Hand Dermatological Practices

Author

Mazzola, Luca, Marceglia, Sara, Bonacina, Stefano, Pinciroli, Francesco, Ayala, Fabio, De Pitá, Ornella, Pigatto, Paolo, Hutchison, David, editor, Kanade, Takeo, editor, Kittler, Josef, editor, Kleinberg, Jon M., editor, Mattern, Friedemann, editor, Mitchell, John C., editor, Naor, Moni, editor, Nierstrasz, Oscar, editor, Pandu Rangan, C., editor, Steffen, Bernhard, editor, Sudan, Madhu, editor, Terzopoulos, Demetri, editor, Tygar, Doug, editor, Vardi, Moshe Y., editor, Weikum, Gerhard, editor, and Duffy, Vincent G., editor

Published
2013
Full Text
View/download PDF

29. The European baseline series and recommended additions: 2023

Author

Wilkinson, S. Mark, primary, Gonçalo, Margarida, additional, Aerts, Olivier, additional, Badulici, Sonia, additional, Dickel, Heinrich, additional, Gallo, Rosella, additional, Garcia‐Abujeta, Jose L., additional, Giménez‐Arnau, Ana M., additional, Hamman, Curt, additional, Hervella, Marcos, additional, Isaksson, Marléne, additional, Johansen, Jeanne D., additional, Mahler, Vera, additional, Niklasson, Bo, additional, Pigatto, Paolo, additional, Ponyai, Gyorgyi, additional, Rustemeyer, Thomas, additional, Schuttelaar, Marie L. A., additional, Spiewak, Radoslaw, additional, Stingeni, Luca, additional, Thyssen, Jacob P., additional, and Uter, Wolfgang, additional

Published
2022
Full Text
View/download PDF

30. Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps

Author

Bagnasco, Diego, primary, Canevari, Rikki Frank, additional, Del Giacco, Stefano, additional, Ferrucci, Silvia, additional, Pigatto, Paolo, additional, Castelnuovo, Paolo, additional, Marseglia, Gian Luigi, additional, Yalcin, Arzu Didem, additional, Pelaia, Girolamo, additional, and Canonica, Giorgio Walter, additional

Published
2022
Full Text
View/download PDF

31. <scp> Myroxylon pereirae </scp> (balsam of Peru): Still worth testing?

Author

Guarneri, Fabrizio, Corazza, Monica, Stingeni, Luca, Patruno, Cataldo, Napolitano, Maddalena, Pigatto, Paolo D M, Gallo, Rosella, Cristaudo, Antonio, Romita, Paolo, Offidani, Annamaria, Schena, Donatella, Milanesi, Nicola, Micali, Giuseppe, Zucca, Myriam, Foti, Caterina, Borghi, Alessandro, Hansel, Katharina, Damiani, Giovanni, Trave, Ilaria, Martina, Emanuela, Dal Bello, Giacomo, Gola, Massimo, Musumeci, Maria Letizia, and Piras, Viviana

Subjects
Male, Balsam of Peru, balsam of Peru, fragrance allergy, fragrance mix 1, Myroxylon pereirae, patch test, 030207 dermatology & venereal diseases, 0302 clinical medicine, Retrospective analysis, Immunology and Allergy, Medicine, 030212 general & internal medicine, Aged, 80 and over, Balsams, biology, Patch test, Middle Aged, Patch Tests, Fragrance allergy, Dermatitis, Allergic Contact, embryonic structures, Original Article, Female, Adult, medicine.medical_specialty, animal structures, Adolescent, Myroxylon pereirae, balsam of Peru, fragrance allergy, fragrance mix 1, patch test, Socio-culturale, Myroxylon, Dermatology, Young Adult, 03 medical and health sciences, Humans, Fragrance mix, Aged, Hexoses, Retrospective Studies, business.industry, fungi, Original Articles, biology.organism_classification, medicine.disease, Odorants, Sorbitan Sesquioleate, sense organs, business, Contact dermatitis
Abstract

Background Because Myroxylon pereirae (MP), or balsam of Peru, is nowadays almost not used “as such,” and fragrance mix 1 (FM1) apparently is more sensitive in detecting fragrance allergy, the usefulness of testing MP in baseline series was recently questioned. Objectives Identification of the number of clinically relevant patch test reactions to MP not detected by FM1. Methods Retrospective analysis of 12 030 patients patch tested with MP and FM1 for contact dermatitis between January 2018 and December 2019 in 13 Italian dermatology clinics. Results Four hundred thirty‐nine patients (3.6%) had a positive patch test reaction to MP; 437 (3.6%) had a positive patch test reaction to FM1. Positive reactions to both MP and FM1 were observed in 119 subjects (1.0%), 310 (2.6%) reacted to MP only, 304 (2.5%) to FM1 only, 5 to MP and sorbitan sesquioleate (SSO), 9 to FM1 and SSO, and 5 to MP, FM1, and SSO. Single sensitizations were clinically relevant in 75.2% of cases for MP (62.9% current, 12.3% past) and 76.3% for FM1 (70.1% current, 6.2% past). Conclusions Based on our results, MP appears to be still worth testing along with FM1 in baseline series, because it allows detection of a remarkable number of fragrance allergies, often relevant, which would be otherwise missed.

Published
2021
Full Text
View/download PDF

33. COVID-19 first lockdown and outpatient hospital setting: a single center, real life study focusing on pattern changes in patients' ethnicities and treated dermatoses

Author

GIRONI, Laura C., primary, ESPOSTO, Elia, additional, GIORGIONE, Roberto, additional, ZAVATTARO, Elisa, additional, FARINELLI, Pamela, additional, GIORDANO, Mara, additional, MELLONE, Simona, additional, BUJA, Alessandra, additional, PIGATTO, Paolo D., additional, DAMIANI, Giovanni, additional, and SAVOIA, Paola, additional

Published
2022
Full Text
View/download PDF

34. National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

Author

Gori, Niccolò, primary, Chiricozzi, Andrea, additional, Marsili, Franco, additional, Ferrucci, Silvia Mariel, additional, Amerio, Paolo, additional, Battarra, Vincenzo, additional, Campitiello, Salvatore, additional, Castelli, Antonio, additional, Congedo, Maurizio, additional, Corazza, Monica, additional, Cristaudo, Antonio, additional, Fabbrocini, Gabriella, additional, Girolomoni, Giampiero, additional, Malara, Giovanna, additional, Micali, Giuseppe, additional, Palazzo, Giovanni, additional, Parodi, Aurora, additional, Patrizi, Annalisa, additional, Pellacani, Giovanni, additional, Pigatto, Paolo, additional, Provenzano, Eugenio, additional, Quaglino, Pietro, additional, Romanelli, Marco, additional, Rossi, Mariateresa, additional, Savoia, Paola, additional, and Peris, Ketty, additional

Published
2022
Full Text
View/download PDF

38. Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing

Author

Prignano, Francesca, primary, Brunasso, Alexandra M. G., additional, Fabbrocini, Gabriella, additional, Argenziano, Giuseppe, additional, Bardazzi, Federico, additional, Borroni, Riccardo G., additional, Burlando, Martina, additional, Cagni, Anna Elisabetta, additional, Campione, Elena, additional, Cinotti, Elisa, additional, Cuccia, Aldo, additional, Dastoli, Stefano, additional, De Pasquale, Rocco, additional, De Simone, Clara, additional, Di Lernia, Vito, additional, Dini, Valentina, additional, Fargnoli, Maria Concetta, additional, Faure, Elisa, additional, Giacchetti, Alfredo, additional, Giofrè, Claudia, additional, Girolomoni, Giampiero, additional, Lasagni, Claudia, additional, Lembo, Serena, additional, Loconsole, Francesco, additional, Montesu, Maria Antonia, additional, Pella, Paolo, additional, Pigatto, Paolo, additional, Richetta, Antonio Giovanni, additional, Stroppiana, Elena, additional, Venturini, Marina, additional, Zichichi, Leonardo, additional, and Piaserico, Stefano, additional

Published
2022
Full Text
View/download PDF

43. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Author

Zuberbier, Torsten, Abdul Latiff, Amir Hamzah, Abuzakouk, Mohamed, Aquilina, Susan, Asero, Riccardo, Baker, Diane, Ballmer-Weber, Barbara, Bangert, Christine, Ben-Shoshan, Moshe, Bernstein, Jonathan A., Bindslev-Jensen, Carsten, Brockow, Knut, Brzoza, Zenon, Chong Neto, Herberto Jose, Church, Martin K., Criado, Paulo R., Danilycheva, Inna V., Dressler, Corinna, Ensina, Luis Felipe, Fonacier, Luz, Gaskins, Matthew, Gáspár, Krisztian, Gelincik, Aslı, Giménez-Arnau, Ana, Godse, Kiran, Gonçalo, Margarida, Grattan, Clive, Grosber, Martine, Hamelmann, Eckard, Hébert, Jacques, Hide, Michihiro, Kaplan, Allen, Kapp, Alexander, Kessel, Aharon, Kocatürk, Emek, Kulthanan, Kanokvalai, Larenas-Linnemann, Désirée, Lauerma, Antti, Leslie, Tabi A., Magerl, Markus, Makris, Michael, Meshkova, Raisa Y., Metz, Martin, Micallef, Daniel, Mortz, Charlotte G., Nast, Alexander, Oude-Elberink, Hanneke, Pawankar, Ruby, Pigatto, Paolo D., Ratti Sisa, Hector, Rojo Gutiérrez, María Isabel, Saini, Sarbjit S., Schmid-Grendelmeier, Peter, Sekerel, Bulent E., Siebenhaar, Frank, Siiskonen, Hanna, Soria, Angele, Staubach-Renz, Petra, Stingeni, Luca, Sussman, Gordon, Szegedi, Andrea, Thomsen, Simon Francis, Vadasz, Zahava, Vestergaard, Christian, Wedi, Bettina, Zhao, Zuotao, Maurer, Marcus, Zuberbier, Torsten, Abdul Latiff, Amir Hamzah, Abuzakouk, Mohamed, Aquilina, Susan, Asero, Riccardo, Baker, Diane, Ballmer-Weber, Barbara, Bangert, Christine, Ben-Shoshan, Moshe, Bernstein, Jonathan A., Bindslev-Jensen, Carsten, Brockow, Knut, Brzoza, Zenon, Chong Neto, Herberto Jose, Church, Martin K., Criado, Paulo R., Danilycheva, Inna V., Dressler, Corinna, Ensina, Luis Felipe, Fonacier, Luz, Gaskins, Matthew, Gáspár, Krisztian, Gelincik, Aslı, Giménez-Arnau, Ana, Godse, Kiran, Gonçalo, Margarida, Grattan, Clive, Grosber, Martine, Hamelmann, Eckard, Hébert, Jacques, Hide, Michihiro, Kaplan, Allen, Kapp, Alexander, Kessel, Aharon, Kocatürk, Emek, Kulthanan, Kanokvalai, Larenas-Linnemann, Désirée, Lauerma, Antti, Leslie, Tabi A., Magerl, Markus, Makris, Michael, Meshkova, Raisa Y., Metz, Martin, Micallef, Daniel, Mortz, Charlotte G., Nast, Alexander, Oude-Elberink, Hanneke, Pawankar, Ruby, Pigatto, Paolo D., Ratti Sisa, Hector, Rojo Gutiérrez, María Isabel, Saini, Sarbjit S., Schmid-Grendelmeier, Peter, Sekerel, Bulent E., Siebenhaar, Frank, Siiskonen, Hanna, Soria, Angele, Staubach-Renz, Petra, Stingeni, Luca, Sussman, Gordon, Szegedi, Andrea, Thomsen, Simon Francis, Vadasz, Zahava, Vestergaard, Christian, Wedi, Bettina, Zhao, Zuotao, and Maurer, Marcus

Abstract

This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell–driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

Published
2022

45. Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey

Author

CASSANO, Nicoletta, primary, GENOVESE, Giovanni, additional, ASERO, Riccardo, additional, CRIMI, Nunzio, additional, CRISTAUDO, Antonio, additional, DAPAVO, Paolo, additional, DE PITÀ, Ornella, additional, FERRUCCI, Silvia, additional, FIERRO, Maria T., additional, FOTI, Caterina, additional, GIROLOMONI, Giampiero, additional, NETTIS, Eustachio, additional, OFFIDANI, Annamaria, additional, PATRIZI, Annalisa, additional, PEPE, Patrizia, additional, PIGATTO, Paolo, additional, STINGENI, Luca, additional, MARZANO, Angelo V., additional, and VENA, Gino A., additional

Published
2022
Full Text
View/download PDF

49. The European baseline series and recommended additions: 2023.

Author

Wilkinson, S. Mark, Gonçalo, Margarida, Aerts, Olivier, Badulici, Sonia, Dickel, Heinrich, Gallo, Rosella, Garcia‐Abujeta, Jose L., Giménez‐Arnau, Ana M., Hamman, Curt, Hervella, Marcos, Isaksson, Marléne, Johansen, Jeanne D., Mahler, Vera, Niklasson, Bo, Pigatto, Paolo, Ponyai, Gyorgyi, Rustemeyer, Thomas, Schuttelaar, Marie L. A., Spiewak, Radoslaw, and Stingeni, Luca

Subjects
ALLERGENS
Abstract

The European baseline series was last updated in 2019. This article discusses the reasoning behind a further iteration of the series for 2023. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

50. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic. risk analysis from the PSO-BIO-COVID observational study

Author

Talamonti, Marina, Galluzzo, Marco, Chiricozzi, Andrea, Quaglino, Pietro, Fabbrocini, Gabriella, Gisondi, Paolo, Marzano, Angelo Valerio, Potenza, Concetta, Conti, Andrea, Parodi, Aurora, Piaserico, Stefano, Bardazzi, Federico, Argenziano, Giuseppe, Rongioletti, Franco, Stingeni, Luca, Micali, Giuseppe, Loconsole, Francesco, Rossi, Maria Teresa, Bongiorno, Maria Rita, Feliciani, Claudio, Rubegni, Pietro, Amerio, Paolo, Fargnoli, Maria Concetta, Pigatto, Paolo, Savoia, Paola, Nisticò, Steven Paul, Giustini, Sandra, Carugno, Andrea, Cannavo', Serafinella Patrizia, Rech, Giulia, Prignano, Francesca, Offidani, Annamaria, Lombardo, Maurizio, Zalaudek, Iris, Bianchi, Luca, Peris, Ketty, PSO-BIO-COVID study group, Balestri R, Bernardini N, Belloni Fortini A, Burlando M, Caldarola G, Campione E, Cattaneo A, Dapavo P, Dastoli S, De Simone C, Di Nuzzo S, Diotallevi F, Fierro MT, Franchi C, Esposito M, Foti C, Gambini DM, Gambardella A, Girolomoni G, Giunta A, Guarneri C, Gualdi G, Hansel K, Megna M, Mugheddu C, Musumeci ML, Patrizi A, Pellacani G, Richetta AG, Rosi E, Sacchelli L, Tiberio R, Tilotta G, Trovato E, Venturini M, Vezzoni R, Talamonti, M., Galluzzo, M., Chiricozzi, A., Quaglino, P., Fabbrocini, G., Gisondi, P., Marzano, A. V., Potenza, C., Conti, A., Parodi, A., Piaserico, S., Bardazzi, F., Argenziano, G., Rongioletti, F., Stingeni, L., Micali, G., Loconsole, F., Rossi, M. T., Bongiorno, M. R., Feliciani, C., Rubegni, P., Amerio, P., Fargnoli, M. C., Pigatto, P., Savoia, P., Nistico, S. P., Giustini, S., Carugno, A., Cannavo', S. P., Rech, G., Prignano, F., Offidani, A., Lombardo, M., Zalaudek, I., Bianchi, L., Peris, K., Talamonti, M, Galluzzo, M, Chiricozzi, A, Quaglino, P, Fabbrocini, G, Gisondi, P, Marzano, A, Potenza, C, Conti, A, Parodi, A, Piaserico, S, Bardazzi, F, Argenziano, G, Rongioletti, F, Stingeni, L, Micali, G, Loconsole, F, Rossi, M, Bongiorno, M, Feliciani, C, Rubegni, P, Amerio, P, Fargnoli, M, Pigatto, P, Savoia, P, Nisticò, S, Giustini, S, Carugno, A, Cannavo’, S, Rech, G, Prignano, F, Offidani, A, Lombardo, M, Zalaudek, I, Bianchi, L, Peris, K, Talamonti, Marina, Galluzzo, Marco, Chiricozzi, Andrea, Quaglino, Pietro, Fabbrocini, Gabriella, Gisondi, Paolo, Marzano, Angelo Valerio, Potenza, Concetta, Conti, Andrea, Parodi, Aurora, Piaserico, Stefano, Bardazzi, Federico, Argenziano, Giuseppe, Rongioletti, Franco, Stingeni, Luca, Micali, Giuseppe, Loconsole, Francesco, Rossi, Maria Teresa, Bongiorno, Maria Rita, Feliciani, Claudio, Rubegni, Pietro, Amerio, Paolo, Fargnoli, Maria Concetta, Pigatto, Paolo, Savoia, Paola, Nisticò, Steven Paul, Giustini, Sandra, Carugno, Andrea, Cannavo', Serafinella Patrizia, Rech, Giulia, Prignano, Francesca, Offidani, Annamaria, Lombardo, Maurizio, Zalaudek, Iri, Bianchi, Luca, Peris, Ketty, PSO-BIO-COVID study, Group, Balestri, R, Bernardini, N, Belloni Fortini, A, Burlando, M, Caldarola, G, Campione, E, Cattaneo, A, Dapavo, P, Dastoli, S, De Simone, C, Di Nuzzo, S, Diotallevi, F, Fierro, Mt, Franchi, C, Esposito, M, Foti, C, Gambini, Dm, Gambardella, A, Girolomoni, G, Giunta, A, Guarneri, C, Gualdi, G, Hansel, K, Megna, M, Mugheddu, C, Musumeci, Ml, Patrizi, A, Pellacani, G, Richetta, Ag, Rosi, E, Sacchelli, L, Tiberio, R, Tilotta, G, Trovato, E, Venturini, M, Vezzoni, R, Talamonti M., Galluzzo M., Chiricozzi A., Quaglino P., Fabbrocini G., Gisondi P., Marzano A.V., Potenza C., Conti A., Parodi A., Piaserico S., Bardazzi F., Argenziano G., Rongioletti F., Stingeni L., Micali G., Loconsole F., Rossi M.T., Bongiorno M.R., Feliciani C., Rubegni P., Amerio P., Fargnoli M.C., Pigatto P., Savoia P., Nistico S.P., Giustini S., Carugno A., Cannavo' S.P., Rech G., Prignano F., Offidani A., Lombardo M., Zalaudek I., Bianchi L., and Peris K.

Subjects
0301 basic medicine, Male, Clinical Biochemistry, Disease, Cohort Studies, 0302 clinical medicine, Drug Discovery, Receptors, 80 and over, Medicine, Aged, 80 and over, education.field_of_study, Incidence (epidemiology), Incidence, Interleukin-17, psoriasis, Middle Aged, dermatology, sars-CoV-2, Italy, biological therapy, 030220 oncology & carcinogenesis, Cohort, Biological Product, COVID-19, Female, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Adult, Aged, Biological Products, Biological Therapy, Chronic Disease, Humans, Pandemics, Psoriasis, Receptors, Interleukin, Risk Assessment, Tumor Necrosis Factor-alpha, Young Adult, Cohort study, Human, medicine.medical_specialty, Population, 03 medical and health sciences, Settore MED/35, Internal medicine, education, Pharmacology, Psoriasi, Pandemic, business.industry, Biological product, Interleukin, medicine.disease, Clinical trial, 030104 developmental biology, SARS-CoV-2, Cohort Studie, business
Abstract

Background The susceptibility of patients with chronic plaque psoriasis and the risks or benefits related to the use of biological therapies for COVID-19 are unknown. Few data about prevalence, clinical course and outcomes of COVID-19 among psoriatic patients were reported. The aims of this study were 1) to assess the prevalence and severity of COVID-19 in psoriatic patients treated with biologic agents during the first phase of the emergency (22 February to 22 April 2020) in Italy, and 2) to report the clinical outcomes of patients who have been exposed to individuals with confirmed SARS-CoV-2 infection. Methods Patients with moderate-to-severe chronic plaque psoriasis, aged ≥18 years and undergoing treatment with biologic agents as of 22 February 2020, were eligible to be included in PSO-BIO-COVID study. Demographic and clinical characteristics of patients using any biologic for psoriasis treatment between 22 February and 22 April 2020 were registered. For all confirmed or suspected cases of COVID-19, data about concomitant disease, ongoing therapies, and comorbidities were also reported. Results A total of 12,807 psoriatic patients were included in the PSO-BIO-COVID study. In this cohort twenty-six patients (0.2%) had a swab confirmation of SARS-CoV-2 infection. Eleven patients required hospitalization and two died. 125 of 12807 patients (1.0%) with exposure to a patient with COVID-19 under quarantine or active health surveillance, were reported. Conclusion The incidence of COVID-19 observed in our cohort of psoriatic patients (0.2%) is similar to that seen in the general population (0.31%) in Italy. However, the course of the disease was mild in most patients. Biological therapies may likely lessen "cytokine storm" of COVID-19, which sometimes lead to multiple organ failure, ARDS, and death.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results